Greg, if we don't RS according to my horrible math- If our stock price reaches $2.04 we can list on the AMEX. That would represent at 17x what the current price is. The market cap would be 1.5 billion. Again with a spinoff, partnership (upfront money) ELTOP, Parkinson's, Diabetes, Grant money, LymPro revenue, acquiring the p16 asset, RP, and MANF MANF MANF developments

So, I agree. Within 2 years. With all of these positive catalysts. Why can't we reach 2 bucks without the RS.